195 related articles for article (PubMed ID: 26784896)
21. Blocked autophagy using lysosomotropic agents sensitizes resistant prostate tumor cells to the novel Akt inhibitor AZD5363.
Lamoureux F; Thomas C; Crafter C; Kumano M; Zhang F; Davies BR; Gleave ME; Zoubeidi A
Clin Cancer Res; 2013 Feb; 19(4):833-44. PubMed ID: 23258740
[TBL] [Abstract][Full Text] [Related]
22. Niclosamide induces apoptosis through mitochondrial intrinsic pathway and inhibits migration and invasion in human thyroid cancer in vitro.
Yu K; Wang T; Li Y; Wang C; Wang X; Zhang M; Xie Y; Li S; An Z; Ye T
Biomed Pharmacother; 2017 Aug; 92():403-411. PubMed ID: 28575805
[TBL] [Abstract][Full Text] [Related]
23. A new niclosamide derivatives-B17 can inhibit urological cancers growth through apoptosis-related pathway.
Wu CL; Chen CL; Huang HS; Yu DS
Cancer Med; 2018 Aug; 7(8):3945-3954. PubMed ID: 29953738
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
[TBL] [Abstract][Full Text] [Related]
25. Niclosamide prevents the formation of large ubiquitin-containing aggregates caused by proteasome inhibition.
Gies E; Wilde I; Winget JM; Brack M; Rotblat B; Novoa CA; Balgi AD; Sorensen PH; Roberge M; Mayor T
PLoS One; 2010 Dec; 5(12):e14410. PubMed ID: 21203451
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of niclosamide on inflammation and migration of fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Liang L; Huang M; Xiao Y; Zen S; Lao M; Zou Y; Shi M; Yang X; Xu H
Inflamm Res; 2015 Apr; 64(3-4):225-33. PubMed ID: 25708600
[TBL] [Abstract][Full Text] [Related]
27. Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects.
Jurgeit A; McDowell R; Moese S; Meldrum E; Schwendener R; Greber UF
PLoS Pathog; 2012; 8(10):e1002976. PubMed ID: 23133371
[TBL] [Abstract][Full Text] [Related]
28. Extracellular pH Modulates Neuroendocrine Prostate Cancer Cell Metabolism and Susceptibility to the Mitochondrial Inhibitor Niclosamide.
Ippolito JE; Brandenburg MW; Ge X; Crowley JR; Kirmess KM; Som A; D'Avignon DA; Arbeit JM; Achilefu S; Yarasheski KE; Milbrandt J
PLoS One; 2016; 11(7):e0159675. PubMed ID: 27438712
[TBL] [Abstract][Full Text] [Related]
29. Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility.
Massoner P; Colleselli D; Matscheski A; Pircher H; Geley S; Jansen Dürr P; Klocker H
Endocr Relat Cancer; 2009 Sep; 16(3):795-808. PubMed ID: 19509068
[TBL] [Abstract][Full Text] [Related]
30. Scavenger receptor-recognized and enzyme-responsive nanoprobe for fluorescent labeling of lysosomes in live cells.
Fan Y; Li F; Chen D
Biomaterials; 2014 Sep; 35(27):7870-80. PubMed ID: 24929616
[TBL] [Abstract][Full Text] [Related]
31. Niclosamide acts as a new inhibitor of vasculogenic mimicry in oral cancer through upregulation of miR-124 and downregulation of STAT3.
Li X; Yang Z; Han Z; Wen Y; Ma Z; Wang Y
Oncol Rep; 2018 Feb; 39(2):827-833. PubMed ID: 29251334
[TBL] [Abstract][Full Text] [Related]
32. Niclosamide, an oral antihelmintic drug, exhibits antimetastatic activity in hepatocellular carcinoma cells through downregulating twist-mediated CD10 expression.
Chien MH; Ho YC; Yang SF; Yang YC; Lai SY; Chen WS; Chen MJ; Yeh CB
Environ Toxicol; 2018 Jun; 33(6):659-669. PubMed ID: 29480568
[TBL] [Abstract][Full Text] [Related]
33. Tetrandrine suppresses proliferation, induces apoptosis, and inhibits migration and invasion in human prostate cancer cells.
Liu W; Kou B; Ma ZK; Tang XS; Lv C; Ye M; Chen JQ; Li L; Wang XY; He DL
Asian J Androl; 2015; 17(5):850-3. PubMed ID: 25677131
[TBL] [Abstract][Full Text] [Related]
34. LIM kinase 1: evidence for a role in the regulation of intracellular vesicle trafficking of lysosomes and endosomes in human breast cancer cells.
Nishimura Y; Yoshioka K; Bernard O; Himeno M; Itoh K
Eur J Cell Biol; 2004 Aug; 83(7):369-80. PubMed ID: 15503860
[TBL] [Abstract][Full Text] [Related]
35. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
Barrett CS; Millena AC; Khan SA
Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827
[TBL] [Abstract][Full Text] [Related]
36. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
[TBL] [Abstract][Full Text] [Related]
37. Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells.
Pan JX; Ding K; Wang CY
Chin J Cancer; 2012 Apr; 31(4):178-84. PubMed ID: 22237038
[TBL] [Abstract][Full Text] [Related]
38. S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide.
Stewart RL; Carpenter BL; West DS; Knifley T; Liu L; Wang C; Weiss HL; Gal TS; Durbin EB; Arnold SM; O'Connor KL; Chen M
Oncotarget; 2016 Jun; 7(23):34630-42. PubMed ID: 27127879
[TBL] [Abstract][Full Text] [Related]
39. Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Cheng TS; Chen WC; Lin YY; Tsai CH; Liao CI; Shyu HY; Ko CJ; Tzeng SF; Huang CY; Yang PC; Hsiao PW; Lee MS
Cancer Prev Res (Phila); 2013 May; 6(5):495-505. PubMed ID: 23466486
[TBL] [Abstract][Full Text] [Related]
40. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.
Parr C; Jiang WG
Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
